Optical surface and ultrasound guidance in radiotherapy – the state-of-the-art

28th February 2020  09:00 - 16:45 (GMT+00:00) GMT

Join us at this great event which features speakers from around the world, including the USA, Germany and Ireland. Delegates will be able to learn about cutting-edge and exemplary practice in this important and rapidly growing field in image-guided radiotherapy. The event aims to provide an overview of best practice in the application of optical surface and ultrasound guidance in radiotherapy.

 

Who should attend:

Clinical oncologists, therapy radiographers, physicists, technologists

 

Learning objectives:

  • To gain an appreciation of best practice application of these technologies
  • To understand how these technologies could be incorporated into the delegates own practice to improve the quality and safety of radiotherapy treatment and improve pathway efficiency

 

View full programme
 

Call for abstracts

Optical surface imaging and ultrasound are beginning to have a significant impact in radiotherapy and have demonstrated benefits in improved accuracy, patient safety and process efficiency.

We would be very pleased to receive proffered abstracts for short oral presentations from authors who wish to share their experience with these technologies.

Submissions would be welcome from clinical oncologists, therapy radiographers, medical physicists, technologists or engineers.

Submit your abstract on our 'call for abstracts' page

Submission deadline: 5pm Monday 23 December 2019

 

Registration fees

BIR Plan 1 member £185

BIR Plan 2 member £125

BIR Trainee member £125

BIR Retired member £65

BIR Student member £65

Non-member £295

 

Venue

Speakers

Sponsors

We are very grateful to the following organisations for supporting this event.

Bayer

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management.

BRAINLAB

Brainlab develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments. Brainlab technology powers treatments in radiosurgery as well as numerous surgical fields including neurosurgery, ENT, CMF, spine and trauma. Founded in Munich in 1989, Brainlab has over 12,850 systems installed in over 100 countries.

C-RAD Positioning AB

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. C-RAD was founded in 2004, all product development is conducted in three fully owned subsidiaries, helping to cure more cancer patients with exceptionally high precision, safety and efficiency.

Elekta

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Siemens Healthineers

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalising healthcare. An estimated 5 million patients globally everyday benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare. For more information and latest product line, please visit https://www.siemens-healthineers.com/en-uk/

Varian

Vision RT

As the leader in Surface Guided Radiation Therapy (SGRT), Vision RT creates technology that tracks a patient’s surface in 3D with sub-half-millimetric accuracy so that radiation is only delivered when the patient is correctly positioned. Widely used on all cancer treatment sites, SGRT particularly benefits left breast cancer treatment by avoiding cardiac damage, and aids in both comfort and speed during brain treatments. Visit www.visionrt.com to learn more.